RT @FrontImmunol: New Research: Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patie…
744 followers
22 followers
RT @FrontImmunol: New Research: Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patie…
338 followers
RT @FrontImmunol: New Research: Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patie…
32,752 followers
New Research: Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients: Background Programmed cell death protein-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors works by… https://t.co/RDqWSM0Q